SSH - DALLAS INC. — History
CCN 452022 | 3-year financial timeline | COVID resilience: 13/100
🛡️ Public data only — no PHI permitted on this instance.
$40M
Latest Revenue (FY2022)
-2.3%
Revenue CAGR (3yr)
1.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $42M | $44M | $40M | -8.9% | -2.3% |
| Operating Expenses | $37M | $38M | $40M | +2.8% | +3.9% |
| Operating Margin | 12.6% | 12.5% | 1.2% | -90.1% | -68.6% |
| Net Income | $5M | $6M | $0M | -91.0% | -69.4% |
| Licensed Beds | 86 | 86 | 58 | -32.6% | -17.9% |
| Total Patient Days | 21,101 | 20,216 | 19,233 | -4.9% | -4.5% |
| Medicare Day % | 37% | 38% | 35% | -7.4% | -2.5% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 13/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -4.6% ($42M → $40M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-2.3%
This Hospital
+7.6%
State Avg
Latest Margin
1.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $39M | -4.4% |
| FY2024 (proj) | $38M | -10.1% |
| FY2025 (proj) | $37M | -15.8% |